David U'Prichard Joins the Board of Directors at Ocimum Biosolutions

Online, March 8, 2010 (Newswire.com) - Hyderabad, India and Gaithersburg, MD, USA, March 8, 2010 - Ocimum Biosolutions, a leading integrated genomics solutions company, today announced that David U'Prichard, President at Druid Consulting LLC, has joined the company's Board of Directors effective immediately. Dr. U'Prichard holds several board positions in life sciences companies globally that include Life Technologies, Inc., Oxagen, Cyclacel and Silence Therapeutics plc. Dr. David U'Prichard is also a venture partner at Red Abbey Venture Partners.

Ms. Anu Acharya, CEO, Ocimum Biosolutions says, "We are delighted to have Dr. David U'Prichard on our Board of Directors. David's wealth of expertise in the biotech and pharma, venture capital and a strong academic background makes him a great source of wisdom for the road ahead for Ocimum. We look forward to a long and fruitful association with David."